Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs

被引:75
作者
Kapetanovic, I. M. [1 ]
Crowell, J. A. [1 ]
Krishnaraj, R. [2 ]
Zakharov, A. [2 ]
Lindeblad, M. [2 ]
Lyubimov, A. [2 ]
机构
[1] NCI, Chemoprevent Agent Dev Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA
[2] Univ Illinois, Toxicol Res Lab, Chicago, IL 60612 USA
关键词
Green tea; Toxicity; Polyphenols; (-)-Epigallocatechin gallate (EGCG); Dogs; Fasted; EPIGALLOCATECHIN-GALLATE EGCG; ORAL BIOAVAILABILITY; MEDICINAL BENEFITS; CAMELLIA-SINENSIS; CATECHINS; CANCER; HEPATOTOXICITY; HEPATITIS; EXTRACTS; SAFETY;
D O I
10.1016/j.tox.2009.03.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Standardized green tea extract was evaluated for exposure and toxicity in Beagle dogs following oral dosing by capsules. The main component (-)-epigallocatechin gallate (EGCG) accounted for 56-72% of the material. A 9-month chronic study (0, 200, 500. and 1000 mg/kg/day) was done in fasted dogs to take advantage of the reported improved catechin bioavailability with fasting. Extensive morbidity, mortality, and pathology of many major organs led to its early termination at 6.5 months and prevented identification of the toxicity mechanisms. A follow-up 13-week study examined the exposure to and toxicity of the extract. In general. toxicities were less severe than in the chronic study during the same interval. Dosing in a fed state resulted in considerably lower and less variable exposure than found under fasted conditions. Toxicity was less frequent and of lesser severity with lower exposure but limited sample size and large variability prevented reaching that definitive conclusion. Differences in mortality and morbidity between the preliminary terminated chronic and follow-up subchronic studies with the same dose of the same drug lot and similar exposure were not fully resolved as there may be other as yet unclear confounding factors. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:28 / 36
页数:9
相关论文
共 38 条
[1]   Serious adverse liver reactions associated with herbal weight-loss supplements [J].
Bjornsson, E. ;
Olsson, Rolf .
JOURNAL OF HEPATOLOGY, 2007, 47 (02) :295-297
[2]   Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis) [J].
Bonkovsky, HL .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (01) :68-71
[3]   Beneficial effects of green tea -: A review [J].
Cabrera, C ;
Artacho, R ;
Giménez, R .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2006, 25 (02) :79-99
[4]   Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats [J].
Cai, Y ;
Anavy, ND ;
Chow, HHS .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) :1246-1249
[6]   Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals [J].
Chow, HHS ;
Hakim, IA ;
Vining, DR ;
Crowel, JA ;
Ranger-Moore, J ;
Chew, WM ;
Celaya, CA ;
Rodney, SR ;
Hara, Y ;
Alberts, DS .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4627-4633
[7]  
Chow HHS, 2003, CLIN CANCER RES, V9, P3312
[8]   Medicinal benefits of green tea:: Part II.: Review of anticancer properties [J].
Cooper, R ;
Morré, J ;
Morré, DM .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 (04) :639-652
[9]   Medicinal benefits of green tea:: Part I.: Review of noncancer health benefits [J].
Cooper, R ;
Morré, DJ ;
Morré, DM .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 (03) :521-528
[10]   A review of the health effects of green tea catechins in in vivo animal models [J].
Crespy, V ;
Williamson, G .
JOURNAL OF NUTRITION, 2004, 134 (12) :3431S-3440S